3647 results for «545»
3647 results
Complications: stable CAD & other coronary interventions
12 May 2021 – From EuroPCR 2021
Have a look at this session if you wish to learn how to handle right coronary artery perforation in a calcified vessel, analyze barotrauma-induced perforation, discover an innovative technique to seal distal wire perforation, and more!
EAPCI-PCR Fellows Course 2021 - Coronary track: Ambiguous LM/PCI strategy for mid-LAD bifurcation
14 Apr 2021 – From EuroPCR 2021
The best PCI strategies for an ambiguous LM, then a mid-LAD bifurcation. With golden tips from G. Stankovic and T. Lefèvre!
The EAPCI-PCR Fellows Course is a project supported by the New Initiatives For Young Interventionalists Committee (NIFYI) and PCR NextGen, and is intended for practitioners at...
EuroPCR 2021 - Innovations in TAVI
18 May 2021 – From EuroPCR 2021
In this session, find out more about an innovative active sealing cuff providing a new strategy to mitigate PVL, post-implantation CT scans to print patient-specific 3D models, transcatheter antiembolic filter, and much more!
Challenging Left Main Cases
18 May 2021 – From EuroPCR 2021
Watch this session to learn how to treat a challenging LM case in a young patient, to question the need to treat residual LAD disease after PPCI for an inferior STEMI, to find out more about complex left main bifurcation PCI with OCT control, and to...
Management of mitral regurgitation patients undergoing TMVI screening
13 Jan 2022
This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.
PANTHER - P2Y12 inhibitor versus aspirin monotherapy in patients with coronary artery disease
30 Aug 2022
Elad Asher provides his take on the PANTHER trial which was presented at the ESC Congress 2022 in Barcelona
Author
Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques (PREVENT)
08 Apr 2024
Ali Nazmi Calik provides his take on the results of the PREVENT trial presented at ACC.24 in Atlanta.
Author
